 Antibodies, Neutralizing
"Antibodies, Neutralizing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.
| Descriptor ID |
D057134
|
| MeSH Number(s) |
D12.776.124.486.485.114.244 D12.776.124.790.651.114.244 D12.776.377.715.548.114.244
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Neutralizing".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Neutralizing".
This graph shows the total number of publications written about "Antibodies, Neutralizing" by people in this website by year, and whether "Antibodies, Neutralizing" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 2 | 2 | | 2010 | 1 | 2 | 3 | | 2011 | 2 | 4 | 6 | | 2012 | 5 | 2 | 7 | | 2013 | 2 | 2 | 4 | | 2014 | 3 | 2 | 5 | | 2015 | 2 | 4 | 6 | | 2016 | 3 | 4 | 7 | | 2017 | 7 | 6 | 13 | | 2018 | 7 | 6 | 13 | | 2019 | 2 | 5 | 7 | | 2020 | 8 | 7 | 15 | | 2021 | 15 | 19 | 34 | | 2022 | 2 | 20 | 22 | | 2023 | 0 | 6 | 6 | | 2024 | 1 | 7 | 8 | | 2025 | 9 | 10 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Neutralizing" by people in Profiles.
-
Yee DS, Davies JP, VanBlargan LA, Rahmberg AR, Burgomaster KE, Brooks K, Flynn JK, Shue B, Ortiz AM, Schaughency P, Best SM, Pierson TC, Brenchley JM. Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species. Sci Adv. 2025 Sep 19; 11(38):eadx9405.
-
Randolph T, Coleman H, Rauch AM, Hubert H, Witeof AE, Walker KD, Funke HH, Garcea RL. Superior immune responses from thermostable, single-administration rabies vaccines prepared using atomic layer deposition. J Pharm Sci. 2025 Sep; 114(9):103936.
-
Parks KR, Moodie Z, Allen MA, Yen C, Furch BD, MacPhee KJ, Ozorowski G, Heptinstall J, Hahn WO, Zheng Z, Lu H, Grant S, Domin E, Duff MO, Seese A, Marini-Macouzet C, Ballweber-Fleming L, Lee WH, Cottrell CA, Liguori A, Georgeson E, Alavi N, Kubitz M, Phelps N, Seaton KE, Cohen KW, Anderson MA, Mondal K, Laufer DS, Kublin JG, Ward AB, Hyrien O, De Rosa SC, Himansu S, Leav B, Reuter C, Tomaras GD, Montefiori D, Walsh SR, Frank I, Sobieszczyk ME, Goepfert PA, Stephenson KE, Baden LR, Van Tieu H, Keefer MC, Clark J, Riddler SA, Schief WR, McElrath MJ. Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Sci Transl Med. 2025 Jul 30; 17(809):eady6831.
-
Knowlton KU, Siegel LK, Barkauskas CE, Bhagani S, Dharan NJ, Gardner EM, Gottlieb RL, Helleberg M, Highbarger HC, Holland TL, Heerfordt CK, Lazarte S, Leither LM, Lutaakome J, Ardelt M, Mylonakis E, Ong SWX, Overcash JS, Taha H, Tien PC, Trautner BW, Vallee D, Weintrob AC, Touloumi G, Babiker AG. Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials. PLoS Med. 2025 Jul; 22(7):e1004616.
-
Nakarin F, Sprenger KG. A paradigm shift in simulating affinity maturation to elicit broadly neutralizing antibodies. Front Immunol. 2025; 16:1627674.
-
Fish LE, Roberts SC, Bennett TD, Carlson NE, Hamer MK, Kwan BM, Russell S, Wogu AF, Wynia MK, Ginde AA. Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325991.
-
Filsinger Interrante MV, Tang S, Kim S, Shanker VR, Hie BL, Bruun TUJ, Wu W, Pak JE, Fernandez D, Kim PS. Utilizing Machine Learning to Improve Neutralization Potency of an HIV-1 Antibody Targeting the gp41 N-Heptad Repeat. ACS Chem Biol. 2025 Jul 18; 20(7):1470-1480.
-
Kim S, Radford CE, Xu D, Zhong J, Do J, Pham DM, Travisano KA, Filsinger Interrante MV, Bruun TUJ, Rezek V, Wilder B, Palomares M, Seaman MS, Kitchen SG, Bloom JD, Kim PS. A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning. Nat Commun. 2025 May 18; 16(1):4617.
-
Janoff EN, Shih MC, Donskey C, Belitskaya-Levy I, Brau N, Rodriguez-Barradas MC, Chan E, Zimmerman P, Miller EK, Vaughan LB, Daniel Markley J, Goldberg AM, Sriram P, Anzueto A, Uyeda L, Zehm L, Wills A, Hutchinson C, Jones L, Peterson D, Ringer RJ, Dumont L, Gleason T, Bonomo RA, Curtis JL, Brown ST. Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1). J Med Virol. 2025 May; 97(5):e70349.
-
Godin A, Brickley EB, Connor RI, Wieland-Alter WF, Ackerman ME, Weiner JA, Modlin J, Arita M, Bandyopadhyay AS, Gast C, Sáez-Llorens X, Rüttimann RW, Van Damme P, De Coster I, Wright PF. Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials. Lancet Microbe. 2025 Jun; 6(6):101028.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|